Doubts Sink Samchundang, Drag K-Bio Down [K-bio pulse]
[Kim Jinsoo, Edaily Reporter] Controversies and suspicions surrounding Samchundang Pharm continued to dampen the pharmaceutical and biotechnology industry on Thursday, leading to widespread declines.
The adverse events originating from Samchundang Pharm have impacted the entire biotech sector, leading to a continued slump in biotech indices and Kosdaq active exchange-traded funds (ETFs).
ETFs holding Samchundang Pharm also failed to avoid the decline.
뉴스픽의 주요 문장 추출 기술을 사용하여 “이데일리” 기사 내용을 3줄로 요약한 결과입니다. 일부 누락된 내용이 있어 전반적인 이해를 위해서는 본문 전체 읽기를 권장합니다.
